Solicitation

Support of early-stage development of small molecules against viral targets.

Person of Contact Maureen Wilson (maureen.wilson2@nih.gov)
Proposal Due Date Tuesday, April 11, 2023 (Closed 1 year ago)
NAICS Codes 54199, 541715
  • Research Category Research & Development Services & Subcontracts
  • Solicitation Number S23-052
  • NCI OA Contract Number 75N91019D00024 – NCI-FFRDC

Description

Leidos Biomedical Research, Inc. is the Operations and Technical Support Services Contractor supporting the Frederick National Laboratory for Cancer Research and will be responsible for awarding the resulting Subcontract(s) in support of Request for Proposal S23-052.

The selected awardee shall support the early-stage development of small molecules against viral targets. The scope shall consist of optimizing antiviral New Chemical Entities via three (3) rounds of structure-activity relationship (SAR) testing. In each round, the small molecules will be assessed in a battery of specific pharmacological tests.

Proposal Instructions

Please contact Maureen Wilson, Sr. Subcontracts Administrator, at maureen.wilson2@nih.gov for the Request for Proposal documents.

NOTE: Proposal questions and request for clarifications are due no later than 4:00 p.m. (ET) Thursday, March 16, 2023 and proposal responses are due no later than 4:00 p.m. (ET) Tuesday, April 11, 2023.